Structured Summary
Abstract
An essential cofactor for the degradation of G(M2)GANGLIOSIDE by lysosomal BETA-N-ACETYLHEXOSAMINIDASES. Genetic mutations resulting in loss of G(M2) activator protein are one of the causes of TAY-SACHS DISEASE, AB VARIANT.
MeSH Record
Classification
Broader headings
Related Concepts
Knowledge Graph
Drag nodes to rearrange; hover to trace links; click a node to open its page.
MeSH Record
See Also
MeSH Record
Synonyms
4 entry terms
- GM(2) Activating Protein
- GM2 Activator Protein
- Hexosaminidase Activator
- Activator Protein, GM2
MeSH Record
Aspects Covered
30 allowable subheadings
Indexed with the subheadings administration & dosage, adverse effects, agonists, analysis, antagonists & inhibitors, biosynthesis, blood, cerebrospinal fluid, chemical synthesis, chemistry, classification, deficiency, drug effects, economics, genetics, history, immunology, isolation & purification, metabolism, pharmacokinetics, pharmacology, physiology, poisoning, radiation effects, standards, supply & distribution, therapeutic use, toxicity, ultrastructure, urine.
MeSH Record
History Note
2005(1983)
MeSH Record
Previous Indexing
- Proteins (1983-2004)
MeSH Hierarchy
Tree Number
AMA Style
References
- National Library of Medicine. G(M2) Activator Protein. Medical Subject Headings (MeSH). 2026. Unique ID D049289. http://id.nlm.nih.gov/mesh/2026/D049289
- G(M2) Activator Protein. In: Wikipedia. https://en.wikipedia.org/wiki/GM2A
- G(M2) Activator Protein. In: Wikidata. https://www.wikidata.org/wiki/Q21125134